Voyager Therapeutics Inc (VYGR) — Free Cash Flow Generation Index

Latest as of March 2024: 0.96x

Voyager Therapeutics Inc (VYGR) has a Free Cash Flow Generation Index of 0.96x as of March 2024. Free cash flow of $56.63 Million represents 1% of operating cash flow ($58.77 Million). See working capital to net assets of Voyager Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$56.63 Million
USD

Operating Cash Flow

$58.77 Million
USD

Capital Expenditures

$2.14 Million
USD

Voyager Therapeutics Inc Free Cash Flow Generation Index (2015–2023)

Historical FCF Generation Index trend for Voyager Therapeutics Inc across 3 annual periods. Explore cash flow to debt ratio of Voyager Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Voyager Therapeutics Inc (2015–2023)

Year-by-year Free Cash Flow Generation Index for Voyager Therapeutics Inc. For the full company profile including market capitalisation, see Voyager Therapeutics Inc stock valuation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.96x $74.66 Million $77.92 Million $3.26 Million ▲ +13.9%
2019 0.84x $40.95 Million $48.67 Million $7.72 Million ▼ -13.7%
2015 0.98x $40.27 Million $41.30 Million $1.03 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).